Comment
doi: 10.1111/ajt.14478.
Epub 2017 Sep 23.
Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?
Affiliations
- PMID: 28858416
- DOI: 10.1111/ajt.14478
Item in Clipboard
Comment
Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?
Am J Transplant.
2017 Nov.
Free article
No abstract available
Keywords: clinical decision-making; clinical research/practice; infection and infectious agents - viral: hepatitis C; liver transplantation/hepatology.
Comment on
-
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.Am J Transplant. 2017 Nov;17(11):2790-2802. doi: 10.1111/ajt.14381. Epub 2017 Jul 1. Am J Transplant. 2017. PMID: 28556422
-
HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?Am J Transplant. 2017 Nov;17(11):2986-2987. doi: 10.1111/ajt.14447. Epub 2017 Aug 21. Am J Transplant. 2017. PMID: 28742943 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
